Lucas Ward
Stock Analyst at Ascendiant Capital
(1.05)
# 3,788
Out of 4,983 analysts
19
Total ratings
42.11%
Success rate
-21.18%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VVOS Vivos Therapeutics | Maintains: Buy | $6.2 → $6.5 | $3.38 | +92.31% | 4 | Sep 9, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Maintains: Buy | $7 → $3 | $1.37 | +118.98% | 3 | Sep 3, 2025 | |
| LIQT LiqTech International | Maintains: Buy | $3.4 → $3.6 | $2.44 | +47.54% | 5 | Jun 16, 2025 | |
| HSCS HeartSciences | Maintains: Buy | $15 → $14 | $3.30 | +324.24% | 2 | Mar 18, 2025 | |
| ACON Aclarion | Maintains: Buy | $555 → $481 | $7.77 | +6,090.72% | 3 | Nov 27, 2024 | |
| VMAR Vision Marine Technologies | Maintains: Buy | $3,375 → $2,700 | $1.42 | +190,040.85% | 2 | Jul 29, 2024 |
Vivos Therapeutics
Sep 9, 2025
Maintains: Buy
Price Target: $6.2 → $6.5
Current: $3.38
Upside: +92.31%
60 Degrees Pharmaceuticals
Sep 3, 2025
Maintains: Buy
Price Target: $7 → $3
Current: $1.37
Upside: +118.98%
LiqTech International
Jun 16, 2025
Maintains: Buy
Price Target: $3.4 → $3.6
Current: $2.44
Upside: +47.54%
HeartSciences
Mar 18, 2025
Maintains: Buy
Price Target: $15 → $14
Current: $3.30
Upside: +324.24%
Aclarion
Nov 27, 2024
Maintains: Buy
Price Target: $555 → $481
Current: $7.77
Upside: +6,090.72%
Vision Marine Technologies
Jul 29, 2024
Maintains: Buy
Price Target: $3,375 → $2,700
Current: $1.42
Upside: +190,040.85%